Pembrolizumab and Enobosarm in Treating Patients With Androgen Receptor Positive Metastatic Triple Negative Breast Cancer

Clinical trial NCT02971761 · COMPLETED

Trial details

NCT number: NCT02971761
Sponsor: City of Hope Medical Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Androgen Receptor Positive Estrogen Receptor Negative HER2/Neu Negative Metastatic Triple-Negative Breast Carcinoma Progesterone Receptor Negative Stage IV Breast Cancer AJCC v6 and v7

Start date: 2017-06-01
Primary completion: 2020-10-28
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.